Immunotherapy After Recent-Onset Type 1 Diabetes: Combinatorial Treatment for Achieving Long-Term Remission in Humans?

Review of Diabetic Studies - Germany
doi 10.1900/rds.2004.1.108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society for Biomedical Diabetes Research (SBDR)

Related search

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Heterogeneity in Recent-Onset Type 1 Diabetes - A Clinical Trial Perspective

Diabetes/Metabolism Research and Reviews
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Immunoablation and Autologous Hematopoietic Stem Cell Transplantation in the Treatment of New-Onset Type 1 Diabetes Mellitus: Long-Term Observations

Bone Marrow Transplantation
TransplantationHematology
2015English

Antigen Specific Treatment for the Inhibition and Remission of Type 1 Diabetes

Japanese Journal of Clinical Immunology
2008English

Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2016English

Long-Term Remission of Refractory Stiff-Man Syndrome After Treatment With Intravenous Immunoglobulin

Mayo Clinic Proceedings
Medicine
1999English

Slowly Progressive Type 1 Diabetes Treated With Metformin for Five Years After Onset

Internal Medicine
Internal MedicineMedicine
2013English

ZnT8 Autoantibody Titers in Type 1 Diabetes Patients Decline Rapidly After Clinical Onset

Autoimmunity
AllergyImmunology
2010English

A Future for CD3 Antibodies in Immunotherapy of Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy